Japanese Concerns Over Blood Bank Contamination By Brian Simpson

Here is yet another blow for the safe and effective narrative of the Covid vax establishment. A recent Japanese study has concluded that receiving blood transfusion from Covid-vaccinated individuals could pose a medical risk to unvaccinated recipients.

Numerous adverse events are being reported among vaccinated people worldwide, and the study said that "post-vaccination thrombosis and subsequent cardiovascular damage, as well as a wide variety of diseases involving all organs and systems, including the nervous system," was being seen, and "a variety of adverse events resulting from genetic vaccines are now being reported worldwide." Thus, medical professionals need to be aware of "various risks associated with blood transfusions using blood products derived from people who have suffered from long COVID and from genetic vaccine recipients, including those who have received mRNA vaccines." "In order to avoid these risks and prevent further expansion of blood contamination and complication of the situation, we strongly request that the vaccination campaign using genetic vaccines be suspended and that a harm–benefit assessment be carried out as early as possible." The Japanese always handled the Covid plandemic better than most of the West.

We can bet good money that Australian health authorities, servants of Big Pharma, will have none of this. After all, for them, the vaxxes are safe and effective with side effects being exceedingly rare. Sure; look, there is another flying pig going by!

https://www.theepochtimes.com/health/japanese-preprint-calls-for-mrna-vaccines-to-be-suspended-over-blood-bank-contamination-concerns-5613006

"Receiving blood transfusion from COVID-19-vaccinated individuals could pose a medical risk to unvaccinated recipients since numerous adverse events are being reported among vaccinated people worldwide, according to a recent study from Japan.

The preprint review, published on March 15, examined whether receiving blood from COVID-19-vaccinated individuals is safe or poses a health risk. Many nations have reported that mRNA vaccine usage has resulted in "post-vaccination thrombosis and subsequent cardiovascular damage, as well as a wide variety of diseases involving all organs and systems, including the nervous system," it said.

Repeated vaccinations can make people more vulnerable to COVID-19, it said. If the blood contains spike proteins, it becomes necessary to remove these proteins prior to administration, and there is no such technology currently available, the authors wrote.

Contrary to earlier expectations, genes and proteins from genetic vaccines have been found to persist in the blood of vaccine recipients for "prolonged periods of time."

In addition, "a variety of adverse events resulting from genetic vaccines are now being reported worldwide." This includes a wide range of diseases related to blood and blood vessels.

Some studies have reported that the spike protein in the mRNA vaccines is neurotoxic and capable of crossing the blood-brain barrier, the review stated. "Thus, there is no longer any doubt that the spike protein used as an antigen in genetic vaccines is itself toxic."

Moreover, people who have taken multiple shots of mRNA vaccines can have several exposures to the same antigen within a small time frame, which may lead to them being "imprinted with a preferential immune response to that antigen."

This has resulted in COVID-19 vaccine recipients becoming "more susceptible to contracting COVID-19."

Given such concerns, medical professionals should be aware of the "various risks associated with blood transfusions using blood products derived from people who have suffered from long COVID and from genetic vaccine recipients, including those who have received mRNA vaccines."

The impact of such genetic vaccines on blood products as well as the actual damage caused by them are currently unknown, the authors wrote.

"In order to avoid these risks and prevent further expansion of blood contamination and complication of the situation, we strongly request that the vaccination campaign using genetic vaccines be suspended and that a harm–benefit assessment be carried out as early as possible."

Repeated vaccination of genetic vaccines can also end up causing "alterations in immune function" among recipients. This raises the risk of serious illnesses due to opportunistic infections or pathogenic viruses, which would not have been an issue if the immune system were normal, the review said.

"Therefore, from the perspective of traditional containment of infectious diseases, greater caution is required in the collection of blood from genetic vaccine recipients and the subsequent handling of blood products, as well as during solid organ transplantation and even surgical procedures in order to avoid the risk of accidental blood-borne infection," it stated.

The review was funded by members of the Japanese Society for Vaccine-related Complications and the Volunteer Medical Association. Authors did not declare any conflict of interest.

The review pointed out that the genetic vaccination status of blood donors is not collected by organizations even though the use of such blood may pose risks to patients. As such, authors recommended that when blood products are derived from such people, "it is necessary to confirm the presence or absence of spike protein or modified mRNA as in other tests for pathogens."

"If the blood product is found to contain the spike protein or a modified gene derived from the genetic vaccine, it is essential to remove them," it stated. "However, there is currently no reliable way to do so."

Since "there is no way to reliably remove the pathogenic protein or mRNA, we suggest that all such blood products be discarded until a definitive solution is found."

The authors pointed out that cases of encephalitis among people who received blood from dengue vaccine recipients were reported as recently as last year. This suggests that the present system of tracking and managing blood products "is not adequate."

Since genetic vaccines were implemented on a global scale for a massive population, "it is expected that the situation will already be complicated" compared to previous drug disasters.

As such, there is an "urgent need" for legislation and international treaties related to the management of blood products, the authors wrote.

The issue of blood transfusion from COVID-19 vaccine recipients has been highly controversial. In 2022, a court in New Zealand ruled against the parents of a sick infant son after they refused blood transfusions from vaccinated people."

https://www.preprints.org/manuscript/202403.0881/v1